These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 25742653)

  • 1. Correction: Targeting and cytotoxicity of SapC-DOPS nanovesicles in pancreatic cancer.
    PLOS ONE Staff
    PLoS One; 2015; 10(3):e0118232. PubMed ID: 25742653
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting and cytotoxicity of SapC-DOPS nanovesicles in pancreatic cancer.
    Chu Z; Abu-Baker S; Palascak MB; Ahmad SA; Franco RS; Qi X
    PLoS One; 2013; 8(10):e75507. PubMed ID: 24124494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of cancer cells using SapC-DOPS nanovesicles.
    Davis HW; Hussain N; Qi X
    Mol Cancer; 2016 May; 15(1):33. PubMed ID: 27160923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SapC-DOPS nanovesicles as targeted therapy for lung cancer.
    Zhao S; Chu Z; Blanco VM; Nie Y; Hou Y; Qi X
    Mol Cancer Ther; 2015 Feb; 14(2):491-8. PubMed ID: 25670331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity and Selectivity in Skin Cancer by SapC-DOPS Nanovesicles.
    Abu-Baker S; Chu Z; Stevens AM; Li J; Qi X
    J Cancer Ther; 2012 Aug; 3(4):321-326. PubMed ID: 25485166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SapC-DOPS - a Phosphatidylserine-targeted Nanovesicle for selective Cancer therapy.
    N'Guessan KF; Patel PH; Qi X
    Cell Commun Signal; 2020 Jan; 18(1):6. PubMed ID: 31918715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles.
    Davis HW; Vallabhapurapu SD; Chu Z; Wyder MA; Greis KD; Fannin V; Sun Y; Desai PB; Pak KY; Gray BD; Qi X
    Cells; 2020 Aug; 9(9):. PubMed ID: 32854321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic cancer: current standards, working towards a new therapeutic approach.
    Olowokure O; Qi X
    Expert Rev Anticancer Ther; 2014 May; 14(5):495-7. PubMed ID: 24621210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles.
    Davis HW; Vallabhapurapu SD; Chu Z; Vallabhapurapu SL; Franco RS; Mierzwa M; Kassing W; Barrett WL; Qi X
    Oncotarget; 2019 Jan; 10(8):856-868. PubMed ID: 30783515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual or combination therapy for pancreatic cancer.
    Davis HW; Kaynak A; Vallabhapurapu SD; Qi X
    World J Gastrointest Oncol; 2021 Jun; 13(6):550-559. PubMed ID: 34163572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SapC-DOPS nanovesicles: a novel targeted agent for the imaging and treatment of glioblastoma.
    Blanco VM; Curry R; Qi X
    Oncoscience; 2015; 2(2):102-110. PubMed ID: 25859553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-selective targeting and cytotoxicity by liposomal-coupled lysosomal saposin C protein.
    Qi X; Chu Z; Mahller YY; Stringer KF; Witte DP; Cripe TP
    Clin Cancer Res; 2009 Sep; 15(18):5840-51. PubMed ID: 19737950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors.
    Jang SC; Kim OY; Yoon CM; Choi DS; Roh TY; Park J; Nilsson J; Lötvall J; Kim YK; Gho YS
    ACS Nano; 2013 Sep; 7(9):7698-710. PubMed ID: 24004438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxymethyl-chitosan-tethered lipid vesicles: hybrid nanoblanket for oral delivery of paclitaxel.
    Joshi N; Saha R; Shanmugam T; Balakrishnan B; More P; Banerjee R
    Biomacromolecules; 2013 Jul; 14(7):2272-82. PubMed ID: 23721348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular volumes of DOPC and DOPS in mixed bilayers of multilamellar vesicles.
    Murugova TN; Balgavý P
    Phys Chem Chem Phys; 2014 Sep; 16(34):18211-6. PubMed ID: 25055002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effects of L-threo-DOPS on electroshock seizure in mice].
    Yoshida M; Nakanishi T
    No To Shinkei; 1989 Jun; 41(6):567-73. PubMed ID: 2508734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine.
    Bartholini J; Constantinidis J; Puig M; Tissot R; Pletscher A
    J Pharmacol Exp Ther; 1975 May; 193(2):523-32. PubMed ID: 1142103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pure akinesia presenting with antecollis].
    Ota S; Tsuchiya K
    No To Shinkei; 2005 Oct; 57(10):893-8. PubMed ID: 16277235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-Dihydroxyphenylserine (L-DOPS): a norepinephrine prodrug.
    Goldstein DS
    Cardiovasc Drug Rev; 2006; 24(3-4):189-203. PubMed ID: 17214596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis of norepinephrine from 3,4-dihydroxyphenylserine by L-aromatic amino acid decarboxylase of the rat brain and kidneys].
    Fujiwara H; Inagaki C; Ikeda Y; Tanaka C
    Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):891-8. PubMed ID: 14060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.